Three randomised controlled trials 182ï¿½184 re ported on the positive effect of pravastatin on arterial outcomes in people with diabetes. One study 182 re ported a significant change in total and LDL cholesterol, HDL cholesterol and triglycerides vs placebo. After 24 weeks the reduction in total cholesterol from baseline was 22%, LDL cholesterol 26%, and triglycerides decreased by 2%, accompanied by an increase in HDL cholesterol of 14%. Pravastatin was well tolerated throughout the study
---
 nice.evidencecategory: Ib
[@Rustemeijer_1997]
[@Raskin_1995]
[@Goldberg_1998]
